Artificial Nucleases for Targeted Single-Stranded DNA Breaks

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for genome editing, such as those using zinc finger nucleases (ZFNs), cannot induce targeted single-stranded breaks (SSBs) or facilitate their repair by homologous recombination in mammalian cells, limiting the ability to achieve targeted integration of transgenes without error-prone non-homologous end-joining (NHEJ) repair.

Innovation Solution

Development of artificial nucleases that generate targeted single-stranded breaks in double-stranded DNA using engineered zinc finger proteins with catalytically inactive cleavage half-domains, which facilitate homologous recombination and targeted integration by forming obligate heterodimers to create single-stranded nicks.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If zinc finger nucleases are used to create double-strand breaks for genome editing, then targeted cleavage at specific genomic locations is achieved, but error-prone non-homologous end-joining repair occurs instead of homologous recombination

Engineering Contradiction:
Improveaccuracy of genome editingVSAvoidprecision of targeted integration
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The invention divides the DNA cleavage function into two separate single-strand cleavage activities instead of one double-strand break. By using two different zinc finger nucleases that each cleave only one strand, the system creates a controlled single-strand break scenario that favors homologous recombination over error-prone NHEJ repair, thereby improving both reliability and precision of targeted integration

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the cleavage parameter from double-strand break to single-strand break by using catalytically inactive cleavage half-domains. This parameter change alters the cellular repair pathway preference from NHEJ to homologous recombination, enabling precise targeted integration while maintaining targeted cleavage capability

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If catalytically inactive cleavage half-domains are used to form obligate heterodimers, then single-stranded breaks are generated for homologous recombination, but the device complexity increases

Engineering Contradiction:
Improveprecision of targeted integrationVSAvoidcomplexity of nuclease system
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The invention merges two zinc finger nuclease components into an obligate heterodimer system where each component contains a catalytically inactive cleavage half-domain. This merging ensures that only when both components are present do they form a functional unit, reducing the need for separate delivery systems and simplifying the overall experimental procedure despite the increased molecular complexity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The catalytically inactive cleavage half-domains act as intermediaries that mediate the interaction between two zinc finger protein components. These intermediaries enable the formation of obligate heterodimers that generate single-strand breaks, facilitating homologous recombination while managing the complexity through controlled protein-protein interactions

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables precise and error-free targeted integration of transgenes into specific genomic locations in mammalian cells, avoiding the errors associated with non-homologous end-joining repair.

Implementation Method 1

artificial nucleases that generate targeted single-stranded breaks in double-stranded DNA using engineered zinc finger proteins with catalytically inactive cleavage half-domains

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Data Source

PatentUS10689717B2Methods and compositions for targeted single-stranded cleavage and targeted integration
Publication Date: 2020.06.23 SANGAMO THERAPEUTICS INC
  • US10689717B2 patent drawing
  • US10689717B2 patent drawing
  • US10689717B2 patent drawing

AI summary

Disclosed herein are methods and compositions for generating a single-stranded break in a target sequence, which facilitates targeted integration of one or more exogenous sequences.